IL1B and laryngotracheoesophageal cleft: After IL-1β-mediated activation of the cyclooxygenase 2 pathway, the microRNA (miRNA) tumor suppressor miR-101 was dramatically reduced in NSCLC cells, suggesting a potential role for IL-1β in LC progression.36